English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
U.S. Food And Drug Administration (fda)
C.D. Marsden
| Apr 18, 2025
FDA Commissioner Makary: 'We are removing industry members—Pharma members—from FDA advisory committees'
Patient Daily Report
| Jul 18, 2023
Dr. Pollet: 'This first procedure is a huge milestone in our journey to help patients find relief'
Patient Daily Report
| Jul 18, 2023
Joe Landolina: "The FDA clearance sets the predicate for our advanced technology and marks Cresilon's first step towards actualizing our long-term goal of expanding our technology within the broader human health market."
Patient Daily Report
| Jul 18, 2023
BioArctic CEO: FDA approval of Leqembi 'is a paradigm-shifting step in the fight against Alzheimer's disease'
Patient Daily Report
| Jul 18, 2023
Woodgrift: 'Leadless pacemakers have been limited to a single chamber device,' until approval of Abbot's new AVEIR DR system
Patient Daily Report
| Jun 27, 2023
Dr. Peter Marks: 'Today's approval addresses an urgent unmet medical need'
Patient Daily Report
| May 25, 2023
FDA approves Opvee, prescription nasal spray opioid reversal agent
Patient Daily Report
| May 23, 2023
Doctor says innovative technology will 'provide the Type 1 diabetes community with additional options and flexibilities for diabetes management'
Trending
Patient Daily
| Aug 12, 2025
Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’
+
Regulatory
Patient Daily
| Aug 14, 2025
Founder of Policy Candy: '340B must see comprehensive reforms'
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+
Pharmaceuticals
Patient Daily
| Aug 14, 2025
PhRMA COO on 340B: 'Hidden tax on patients, taxpayers & employers'
1
2
3
4
…
»
Last »